Repligen
RGEN
#2611
Rank
โ‚น626.62 B
Marketcap
โ‚น11,110
Share price
3.89%
Change (1 day)
18.36%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚น7.35 Billion

According to Repligen 's latest financial reports the company's current earnings are โ‚น0.73 Billion. , an increase over its 2024 earnings that were of -โ‚น0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น7.78 B-1430.84%
2024 -โ‚น0.59 Billion-113.01%
2023 โ‚น4.49 B-78.01%
2022 โ‚น20.43 B33.37%
2021 โ‚น15.32 B131.52%
2020 โ‚น6.61 B101.31%
2019 โ‚น3.28 B25.93%
2018 โ‚น2.61 B105.61%
2017 โ‚น1.26 B-11.46%
2016 โ‚น1.43 B14.91%
2015 โ‚น1.24 B20.26%
2014 โ‚น1.03 B-51.49%
2013 โ‚น2.13 B90.98%
2012 โ‚น1.12 B
2010 โ‚น16.23 M-103.81%
2009 -โ‚น0.43 Billion-223.84%
2008 โ‚น0.34 B
2006 -โ‚น0.24 Billion229.64%
2005 -โ‚น70.03 Million-89.16%
2004 -โ‚น0.65 Billion-16.86%
2003 -โ‚น0.78 Billion88.72%
2002 -โ‚น0.42 Billion-27.88%
2001 -โ‚น0.58 Billion-1.74%
2000 -โ‚น0.59 Billion85.93%
1999 -โ‚น0.32 Billion159.16%
1998 -โ‚น0.13 Billion85.71%
1997 -โ‚น64.94 Million-70.83%
1996 -โ‚น0.23 Billion-72.41%
1995 -โ‚น0.81 Billion-60.63%
1994 -โ‚น2.06 Billion45.39%
1993 -โ‚น1.42 Billion39.45%
1992 -โ‚น1.02 Billion-32.3%
1991 -โ‚น1.5 Billion6.62%
1990 -โ‚น1.41 Billion1577.78%
1989 -โ‚น83.49 Million-57.14%
1988 -โ‚น0.2 Billion-362.5%
1987 โ‚น74.21 M-130.77%
1986 -โ‚น0.25 Billion136.36%
1985 -โ‚น0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น945.46 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น677.92 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.005 T 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น865.31 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.12 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น34.78 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น59.04 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น11.45 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น44.75 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚น9.24 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA